Myasthenia gravis in a patient affected by glycogen storage disease type Ib: A further manifestation of an increased risk for autoimmune disorders?

Journal of Inherited Metabolic Disease

Volumn 31, Issue SUPPL. 2, 2008, Pages

  Melis, D ^a   Balivo, F ^a   Della Casa, R ^a   Romano, A ^a   Taurisano, R ^a   Capaldo, B ^a   Riccardi, G ^a   Monsurro M R ^b   Parenti, G ^a   Andria, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; IMMUNOGLOBULIN; STEROID;

ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; DYSPHAGIA; DYSPNEA; FATIGUE; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; IMMUNOLOGY; MYASTHENIA GRAVIS; NEUROLOGIC EXAMINATION; NEUROMUSCULAR SYNAPSE; PATHOPHYSIOLOGY; PERIPHERAL NERVE; PTOSIS; RESPIRATORY FAILURE; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AUTOIMMUNITY; BLEPHAROPTOSIS; CHOLINESTERASE INHIBITORS; DEGLUTITION DISORDERS; DYSPNEA; FATIGUE; FEMALE; GLYCOGEN STORAGE DISEASE TYPE I; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MYASTHENIA GRAVIS; NEUROLOGIC EXAMINATION; NEUROMUSCULAR JUNCTION; PERIPHERAL NERVES; RESPIRATORY INSUFFICIENCY; RISK ASSESSMENT; RISK FACTORS; STEROIDS; TREATMENT OUTCOME;

EID: 84855612053     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-008-0810-4     Document Type: Article

References (21)

1. Burges J, Vincent A, Molenaar PC, et al (1994) Passive transfer of seronegative myasthenia gravis to mice. Muscle Nerve 17:1393-1400.
2. Calderwood S, Kilpatrick L, Douglas SD, et al (2001) Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood 97:376-382.
3. Chen YT (2001) Glycogen storage disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1521-1551.
4. Chou JY, Matern D, Mansfield BC, Chen YT (2002) Type I glycogen storage disease: disorders of the glucose-6-phosphatase complex. Curr Mol Med 2:121-143.
5. Conti-Fine BM, Milani M, Kaminski HJ (2006) Myasthenia gravis: past, present, and future. J Clin Invest 116:2843-2854.
6. Dieckgraefe BK, Korzenik JR, Husain A, Dieruf L (2002) Association of glycogen storage disease 1b and Crohn disease: results of a North American survey. Eur J Pediatr 161:S88-S92.
7. Evoli A, Batocchi AP, Lo Monaco M, et al (1996) Clinical heterogeneity of sieronegative myasthenia gravis. Neuromusc Disord 6:155-161.
8. Folwaczny C, Glas J, Torok HP (2003) Crohn's disease: an immunodeficiency? Eur J Gastroenterol Hepatol 15:621-626.
9. Gajdos P (2004) Seronegative myasthenia gravis. [In French]. Rev Neurol (Paris) 160:159-162.
10. Jaretzki A, Barhon RJ, Ernstoff RM, et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16-23.
11. Kim SY, Nguyen AD, Gao JL, et al (2006) Bone marrowderived cells require a functional glucose 6-phosphate transporter for normal myeloid functions. J Biol Chem 281:28794-28801.
12. Leuzzi R, Banhegyi G, Kardon T, et al (2003). Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b. Blood 101:2381-2387.
13. Magistretti PJ, Allaman I (2007) Glycogen: a Trojan horse for neurons. Nat Neurosci 10:1341-1342.
14. Meager A, Wadhwa M, Bird C, et al (1999) Spontaneously occurring neutralizing antibodies against granulocytemacrophage colony-stimulating factor in patients with autoimmune disease. Immunology 97:526-532.
15. Melis D, Parenti G, Della Casa R, et al (2003) Crohn's-like ileocolitis in patients affected by glycogen storage disease Ib: two years' follow-up of patients with a wide spectrum of gastrointestinal signs. Acta Paediatrica 92:1415-1421.
16. Melis D, Pivonello R, Parenti G et al (2007) Increased prevalance of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type 1. J Pediatr 150:300-305.
17. Ozen S, Ruperto N, Dillon MJ, et al (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65:936-941.
18. Romagnani S (1994) Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227-257.
19. Sheng JR, Li L, Ganesh BB, Vasu C, et al (2006) Suppression of experimental autoimmune myasthenia gravis by granulocytemacrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells. J Immunol 177:5296-5306.
20. Sleasman JW (1996) The association between immunodeficiency and the development of autoimmune disease. Adv Dent Res 10:57-61.
21. Visser G, Rake JP, Fernandes J, et al (2000) Neutropenia, neutophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of European Study on Glycogen Storage Disease type I. J Pediatr 137:187-191.